AbbVie Inc. (NYSE: ABBV), a United States-based pharmaceutical company, announced on Friday its quarterly cash dividend.
The company has declared cash dividend of USD1.55 per share.
The cash dividend will be paid to stockholders of record at 15 July 2024 on 15 August 2024.
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ
Sirum collaborates with Governor Wes Moore to expand medication access across Maryland
Genomma Lab Internacional announces quarterly dividend
Abbott announces quarterly common dividend
West Pharmaceutical Services announces Q2 dividend
hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026
OptiBiotix expands into Indian market with Amazon launch
Poxel to receive royalties and sales-based payment from Sumitomo Pharma
ReciBioPharm secures grant to expand RNA manufacturing in LMICs
CVS Health to pays common stock quarterly dividend of USD0.665 per share